Moderna (MRNA) Shares Issued: 2018-2025
Historic Shares Issued for Moderna (MRNA) over the last 7 years, with Sep 2025 value amounting to $2.0 million.
- Moderna's Shares Issued fell 75.00% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.0 million, marking a year-over-year decrease of 57.14%. This contributed to the annual value of $66.0 million for FY2024, which is 43.48% up from last year.
- Moderna's Shares Issued amounted to $2.0 million in Q3 2025, which was down 85.71% from $14.0 million recorded in Q2 2025.
- Moderna's 5-year Shares Issued high stood at $36.0 million for Q2 2021, and its period low was $2.0 million during Q3 2025.
- Its 3-year average for Shares Issued is $11.9 million, with a median of $11.0 million in 2024.
- In the last 5 years, Moderna's Shares Issued crashed by 97.24% in 2021 and then surged by 100.00% in 2024.
- Over the past 5 years, Moderna's Shares Issued (Quarterly) stood at $28.0 million in 2021, then decreased by 10.71% to $25.0 million in 2022, then plummeted by 40.00% to $15.0 million in 2023, then dropped by 26.67% to $11.0 million in 2024, then tumbled by 75.00% to $2.0 million in 2025.
- Its last three reported values are $2.0 million in Q3 2025, $14.0 million for Q2 2025, and $3.0 million during Q1 2025.